why choose us

Course: Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021

CME Credits: 1.00

Released: 2021-09-02

High SARS-CoV-2 antibody levels have been achieved in most of the population in high-income countries through vaccination. However, global inequity exists in COVID-19 vaccine distribution, as highlighted at the June 2021 G7 Summit, which committed to providing 1 billion doses to low-income countries. This focus on doses overlooks the pace of transmission in low-income settings.


Educational Objective
To identify the key insights or developments described in this article


View Full Course